Prestige BioPharma (XKRX:950210) EBIT per Share : ₩-750.44 (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Prestige BioPharma EBIT per Share?

Prestige BioPharma's EBIT per Share for the three months ended in Sep. 2024 was ₩-254.70. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-750.44.

During the past 3 years, the average EBIT per Share Growth Rate was -43.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Prestige BioPharma's EBIT per Share or its related term are showing as below:

XKRX:950210' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -43.2 Med: -43.2 Max: -43.2
Current: -43.2

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Prestige BioPharma was -43.20% per year. The lowest was -43.20% per year. And the median was -43.20% per year.

XKRX:950210's 3-Year EBIT Growth Rate is ranked worse than
87.58% of 1248 companies
in the Biotechnology industry
Industry Median: 2.8 vs XKRX:950210: -43.20

Prestige BioPharma's EBIT for the three months ended in Sep. 2024 was ₩-15,503 Mil.

Prestige BioPharma EBIT per Share Historical Data

The historical data trend for Prestige BioPharma's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige BioPharma EBIT per Share Chart

Prestige BioPharma Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

EBIT per Share

-254.92

-142.42

-3,505.54

-19.13

-788.53

Prestige BioPharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial														-286.19	-315.11	-277.13	96.50	-254.70

Prestige BioPharma EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Prestige BioPharma's EBIT per Share for the fiscal year that ended in Jun. 2024 is calculated as

	EBIT per Share		(A: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-47285.21	/	59.966
=	-788.53

Prestige BioPharma's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-15503.13	/	60.869
=	-254.70

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-750.44

Prestige BioPharma (XKRX:950210) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Prestige BioPharma EBIT per Share Related Terms

Thank you for viewing the detailed overview of Prestige BioPharma's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige BioPharma Ltd (XKRX:950210) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Science Park Drive No. 04-13/14, Ascent Tower B, Singapore Science Park, Singapore, SGP, 118222

Website

https://www.prestigebiopharma.com

Prestige BioPharma Ltd is a biopharmaceutical company. The company is focused on the development of biosimilars and new antibody therapeutics. It focuses on oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis.

Prestige BioPharma Headlines

No Headlines